Congress admits biosafety gaps

This in from news editor Alla Katsnelson: At a congressional hearing on linkurl:biosafety;http://www.the-scientist.com/news/display/53626/ today (October 4), the Government Accountability Office reported that the federal government doesn't know how many labs are involved in biosafety level 3 and level 4 work, or where those labs are. Although labs working with certain "select agents" are under the oversight of the CDC, labs working with other pathogens such as SARS or Hantavirus a

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
This in from news editor Alla Katsnelson: At a congressional hearing on linkurl:biosafety;http://www.the-scientist.com/news/display/53626/ today (October 4), the Government Accountability Office reported that the federal government doesn't know how many labs are involved in biosafety level 3 and level 4 work, or where those labs are. Although labs working with certain "select agents" are under the oversight of the CDC, labs working with other pathogens such as SARS or Hantavirus are not required to report mishaps. "No single federal agency, according to 12 agencies' response to our survey, has the mission to track the overall numbers of BSL3 and BSL4 labs in the United States," the GAO wrote in linkurl:testimony;http://energycommerce.house.gov/cmte_mtgs/110-oi-hrg.100407.BSL.shtml submitted to the hearing. "Consequently, no agency is responsible for determining the risks associated with the proliferation of these labs. " The GAO's report counted 17 federal agencies funding BSL3 or BSL4 research.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Alison McCook

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo